‘Unacceptable Safety Risk’: Major European Country Bans Puberty Blockers For Minors
The United Kingdom (UK) indefinitely banned the use of puberty-blocking drugs for minors Wednesday after recommendations from experts that warned of an “unacceptable safety risk.” The ban affects the sale and supply of…


The United Kingdom (UK) indefinitely banned the use of puberty-blocking drugs for minors Wednesday after recommendations from experts that warned of an “unacceptable safety risk.”
The ban affects the sale and supply of the drugs to all citizens under 18 following an independent review by the Commission on Human Medicines, according to a press release from the British government. The ban will be reviewed in 2027.
“The Commission on Human Medicines (CHM) has provided independent expert advice that there is currently an unacceptable safety risk in the continued prescription of puberty blockers to children,” the statement reads. “It recommends indefinite restrictions while work is done to ensure the safety of children and young people.”
The UK previously halted the prescription of puberty blockers for children in March after it found “insufficient evidence to show they were safe.”
Other “gender services” for children will continue in the nation, the release stated. Patients that have already been prescribed the drugs will still have access to them.
“We are working with NHS England to open new gender identity services, so people can access holistic health and wellbeing support they need,” Health and Social Care Secretary Wes Streeting said in a statement. “We are setting up a clinical trial into the use of puberty blockers next year, to establish a clear evidence base for the use of this medicine.”
The UK’s only youth gender clinic, Tavistock Centre, was shut down



